Essex Investment Management CO LLC Cns Pharmaceuticals, Inc. Transaction History

Essex Investment Management CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$1.71 - $2.42 $101,856 - $144,147	-59,565 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$1.72 - $4.18 $2,996 - $7,281	-1,742 Reduced 2.84%	59,565 $142,000
Q4 2020 Feb 12, 2021	SELL	$1.68 - $2.89 $430 - $739	-256 Reduced 0.42%	61,307 $109,000
Q3 2020 Nov 12, 2020	SELL	$1.69 - $2.64 $16,198 - $25,304	-9,585 Reduced 13.47%	61,563 $108,000
Q2 2020 Aug 04, 2020	SELL	$2.0 - $3.7 $692 - $1,280	-346 Reduced 0.48%	71,148 $152,000
Q1 2020 May 04, 2020	SELL	$1.45 - $4.99 $8,647 - $29,760	-5,964 Reduced 7.7%	71,494 $150,000
Q4 2019 Feb 10, 2020	BUY	$3.73 - $4.57 $288,918 - $353,983	77,458 New	77,458 $306,000

100

Ticker CNSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,032,500
Market Cap $4.4M
Description
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.